These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 33317205)

  • 41. Outcomes of kidney retransplantation after graft loss as a result of BK virus nephropathy in the era of newer immunosuppressant agents.
    Leeaphorn N; Thongprayoon C; Chon WJ; Cummings LS; Mao MA; Cheungpasitporn W
    Am J Transplant; 2020 May; 20(5):1334-1340. PubMed ID: 31765056
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HLA-G 3' untranslated region gene variants are promising prognostic factors for BK polyomavirus replication and acute rejection after living-donor kidney transplant.
    Rohn H; Schwich E; Tomoya Michita R; Schramm S; Dolff S; Gäckler A; Korth J; Heinemann FM; Wilde B; Trilling M; Horn PA; Kribben A; Witzke O; Rebmann V
    Hum Immunol; 2020 Apr; 81(4):141-146. PubMed ID: 31679637
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HLA-E Polymorphism Determines Susceptibility to BK Virus Nephropathy after Living-Donor Kidney Transplant.
    Rohn H; Michita RT; Schramm S; Dolff S; Gäckler A; Korth J; Heinemann FM; Wilde B; Trilling M; Horn PA; Kribben A; Witzke O; Rebmann V
    Cells; 2019 Aug; 8(8):. PubMed ID: 31394776
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Combined association of recipient killer cell immunoglobulin-like haplotype AA and donor HLA-C*07 gene with BK virus associated nephropathy in kidney transplant patients.
    Kovacevic Vojtusek I; Burek Kamenaric M; Ivkovic V; Bulimbasic S; Marekovic I; Coric M; Bosnjak Z; Grubic Z; Zunec R
    HLA; 2019 Dec; 94 Suppl 2():4-10. PubMed ID: 31361395
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Natural Killer Cells in Kidney Health and Disease.
    Turner JE; Rickassel C; Healy H; Kassianos AJ
    Front Immunol; 2019; 10():587. PubMed ID: 30972076
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Source and Relevance of the BK Polyomavirus Genotype for Infection After Kidney Transplantation.
    Wunderink HF; De Brouwer CS; Gard L; De Fijter JW; Kroes ACM; Rotmans JI; Feltkamp MCW
    Open Forum Infect Dis; 2019 Mar; 6(3):ofz078. PubMed ID: 30949528
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of human leukocyte antigen and calculated panel reactive antibody on BK viremia in kidney transplant recipients: A single-center experience and literature review.
    El-Husseini A; Hassan W; Yaseen M; Suleiman B; Saleh S; Malik O; Ashqar H; Maibam A; Mei X; Castellanos AL; Cornea V; Gedaly R; Waid T
    Transpl Infect Dis; 2019 Aug; 21(4):e13071. PubMed ID: 30866136
    [TBL] [Abstract][Full Text] [Related]  

  • 48. BK polyomavirus in solid organ transplantation-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.
    Hirsch HH; Randhawa PS;
    Clin Transplant; 2019 Sep; 33(9):e13528. PubMed ID: 30859620
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Human NK cells: surface receptors, inhibitory checkpoints, and translational applications.
    Sivori S; Vacca P; Del Zotto G; Munari E; Mingari MC; Moretta L
    Cell Mol Immunol; 2019 May; 16(5):430-441. PubMed ID: 30778167
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Incidence, risk factors, and outcome of BK polyomavirus infection after kidney transplantation.
    Favi E; Puliatti C; Sivaprakasam R; Ferraresso M; Ambrogi F; Delbue S; Gervasi F; Salzillo I; Raison N; Cacciola R
    World J Clin Cases; 2019 Feb; 7(3):270-290. PubMed ID: 30746369
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognosis of BK polyomavirus nephropathy: 10-year analysis of 133 renal transplant recipients at a single center.
    Chen XT; Yang SC; Li J; Deng RH; Chen WF; Qiu J; Chen LZ; Wang CX; Huang G
    Chin Med J (Engl); 2019 Feb; 132(4):388-394. PubMed ID: 30707175
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reducing calcineurin inhibitor first for treating BK polyomavirus replication after kidney transplantation: long-term outcomes.
    Bischof N; Hirsch HH; Wehmeier C; Amico P; Dickenmann M; Hirt-Minkowski P; Steiger J; Menter T; Helmut H; Schaub S
    Nephrol Dial Transplant; 2019 Jul; 34(7):1240-1250. PubMed ID: 30476254
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Natural killer cell infiltration is discriminative for antibody-mediated rejection and predicts outcome after kidney transplantation.
    Yazdani S; Callemeyn J; Gazut S; Lerut E; de Loor H; Wevers M; Heylen L; Saison C; Koenig A; Thaunat O; Thorrez L; Kuypers D; Sprangers B; Noël LH; Van Lommel L; Schuit F; Essig M; Gwinner W; Anglicheau D; Marquet P; Naesens M
    Kidney Int; 2019 Jan; 95(1):188-198. PubMed ID: 30396694
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risk factors for BK virus viremia and nephropathy after kidney transplantation: A systematic review.
    Demey B; Tinez C; François C; Helle F; Choukroun G; Duverlie G; Castelain S; Brochot E
    J Clin Virol; 2018 Dec; 109():6-12. PubMed ID: 30343190
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An unusually high substitution rate in transplant-associated BK polyomavirus in vivo is further concentrated in HLA-C-bound viral peptides.
    Domingo-Calap P; Schubert B; Joly M; Solis M; Untrau M; Carapito R; Georgel P; Caillard S; Fafi-Kremer S; Paul N; Kohlbacher O; González-Candelas F; Bahram S
    PLoS Pathog; 2018 Oct; 14(10):e1007368. PubMed ID: 30335851
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epidemiology of and Risk Factors for BK Polyomavirus Replication and Nephropathy in Pediatric Renal Transplant Recipients: An International CERTAIN Registry Study.
    Höcker B; Schneble L; Murer L; Carraro A; Pape L; Kranz B; Oh J; Zirngibl M; Dello Strologo L; Büscher A; Weber LT; Awan A; Pohl M; Bald M; Printza N; Rusai K; Peruzzi L; Topaloglu R; Fichtner A; Krupka K; Köster L; Bruckner T; Schnitzler P; Hirsch HH; Tönshoff B
    Transplantation; 2019 Jun; 103(6):1224-1233. PubMed ID: 30130322
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Kidney transplant recipients with polycystic kidney disease have a lower risk of post-transplant BK infection than those with end-stage renal disease due to other causes.
    Plafkin C; Singh T; Astor BC; Parajuli S; Bhutani G; Safdar N; Panzer SE
    Transpl Infect Dis; 2018 Dec; 20(6):e12974. PubMed ID: 30102820
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reduced Risk of BK Polyomavirus Infection in HLA-B51-positive Kidney Transplant Recipients.
    Wunderink HF; Haasnoot GW; de Brouwer CS; van Zwet EW; Kroes ACM; de Fijter JW; Rotmans JI; Claas FHJ; Feltkamp MCW
    Transplantation; 2019 Mar; 103(3):604-612. PubMed ID: 30048396
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term prognosis of BK virus-associated nephropathy in kidney transplant recipients.
    Park WY; Kang SS; Jin K; Park SB; Choe M; Han S
    Kidney Res Clin Pract; 2018 Jun; 37(2):167-173. PubMed ID: 29971212
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Kidney Transplantation: The Challenge of Human Leukocyte Antigen and Its Therapeutic Strategies.
    Alelign T; Ahmed MM; Bobosha K; Tadesse Y; Howe R; Petros B
    J Immunol Res; 2018; 2018():5986740. PubMed ID: 29693023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.